Business
New Teva CEO Kare Schultz will earn an annual salary of $2 million and a performance-dependent bonus of 140% - and up to a...
Hi, what are you looking for?
Jewish Business News
All posts tagged "Erez Vigodman"
Business
Teva appointed Dr. Yitzhak Peterburg as Interim, succeeding Erez Vigodman. Dr. Sol J. Barer named Chairman of the Board
Business
Teva bought its 4.6% stake in Mylan at prices of $69-74 per share. the share price is down sharply in premarket trading.
Business
The groups told the US FTC: Increased consolidation has already led to higher prices and to generic drug shortages.
Business
Last week Teva CEO, Erez Vigodman said, “If the Mylan Pharmaceuticals shareholders support the acquisition of Perrigo, Teva will abandon its bid for Mylan.”
Business
Erez Vigodman: Size isn't everything; it's important to be better.
Business
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has completed first step to buy its rival Mylan N.V. (Nasdaq: MYL). The Israeli giant announced...
Business
Teva is now close to the 4.6% stake in Mylan that will give it standing in the Netherlands courts.
Business
A Credit Suisse study finds that most hostile bids fail, especially if antitrust concerns are involved.
Business
Teva Chairman Yitzhak Peterburgand and Teva’s CEO Erez Vigodman, are pushing Mylan to take Teva’s $40 billion take-over bid offer seriously.